Immunic | VTL - Assets


Immunic reported $189.74M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
BioMarin Pharmaceutical USD 8.59B 996.99M Mar/2026
Cipla INR 424.96B 23.32B Mar/2026
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 156.57M 58.73M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Enanta Pharmaceuticals USD 329.5M 48.77M Dec/2025
Grifols EUR 23.15B 142.7M Dec/2025
Immunic USD 189.74M 165.69M Mar/2026
Insmed USD 2.08B 188.7M Mar/2026
Omeros USD 200.57M 34.59M Jun/2025
OraSure Technologies USD 379.17M 24M Mar/2026
Quidel USD 5.63B 140.6M Mar/2026
Ultragenyx Pharmaceutical USD 1.3B 236M Mar/2026
United Therapeutics USD 6.71B 1.17B Mar/2026
Xoma USD 263.15M 39.7M Sep/2025